Associate Chief Physician, Director of Photodynamic Center, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, China
Dr. Xiaojie Liu is the Associate Chief Physician and Director of the Photodynamic Center at the Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital. With deep expertise in dermatology and oncology, she has emerged as a pioneering clinician-scientist in the advancement of photodynamic therapy (PDT) for malignant skin tumors. Her work bridges clinical practice, innovative treatment design, and advanced diagnostic imaging to set new standards in non-invasive cancer care. Through her leadership in multidisciplinary treatment development and contributions to evidence-based protocols, she has shaped the integration of traditional Chinese and Western medicine approaches in dermatological oncology.
Professional Profile
Scopus Profile
Education
Dr. Liu received her medical and specialist training in dermatology with a strong focus on oncology, medical imaging, and therapeutic interventions. She built her academic foundation in traditional Chinese medicine while acquiring expertise in modern dermatological treatment strategies. This combined training has enabled her to construct innovative treatment protocols that incorporate holistic patient care while relying on cutting-edge technologies such as dermoscopic imaging and real-time monitoring of oncologic responses. Her educational background reflects a unique integration of classical knowledge and modern evidence-based practices, positioning her as a key figure in translational dermatology.
Experience
As Associate Chief Physician, Dr. Liu has been instrumental in developing and supervising treatment programs for skin tumors, especially basal cell carcinoma (BCC) and Bowen’s disease. In her role as Director of the Photodynamic Center, she has coordinated multidisciplinary teams to design PDT-centered treatment frameworks that integrate clinical oncology, imaging technologies, and dermatological surgery. She has also overseen the establishment of longitudinal management systems that emphasize real-time monitoring, patient adherence, and comprehensive post-treatment surveillance. Dr. Liu’s clinical leadership has not only improved oncologic outcomes but has also shaped institutional strategies for the adoption of PDT as a standard of care in high-risk dermatological cases.
Research Focus
Dr. Liu’s research concentrates on advancing photodynamic therapy as a transformative treatment for malignant skin tumors. Her work specifically addresses the treatment of high-risk basal cell carcinoma, including morphoeic and other complex subtypes that traditionally present clinical challenges. By combining electrodesiccation with photodynamic therapy, she has pioneered minimally invasive protocols that improve tumor clearance rates while preserving healthy tissue. She has also introduced dermoscopic surveillance techniques with micron-level precision, enabling earlier detection of treatment responses and recurrence. Her ongoing projects include the construction of an intelligent full-course management system for skin diseases, which integrates traditional Chinese and Western diagnostic models into a unified platform for dermatological oncology care.
Publication Top Note
Title: Benefits of natural edible ingredients in epidermal permeability barrier function
Journal: Chinese Medical Journal
Summary: This study shows that natural edible ingredients enhance skin barrier function by improving hydration, regulating lipids, and strengthening defense, offering safe adjunct options for dermatological care.
Conclusion
Dr. Xiaojie Liu’s contributions to dermatology and oncology epitomize the spirit of clinical innovation and translational research. By pioneering combined therapeutic protocols, developing intelligent management systems, and integrating dermoscopic imaging into routine practice, she has advanced photodynamic therapy from a niche procedure to a cornerstone of dermatological oncology care. Her publications provide robust evidence of the clinical efficacy and safety of these interventions, while her leadership ensures their broad application in multidisciplinary contexts. With a vision focused on harmonizing traditional and modern approaches, Dr. Liu continues to redefine patient-centered care in skin oncology. Her innovative strategies, scientific rigor, and clinical leadership make her a highly deserving candidate for the Best Innovation Award.